Candida glabrata emerges as the most common cause of candidemia: analysis of a large hospital-based database, United States, 2016–2024
Top Cited Papers
- 13 April 2026
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (1) , e109-e112
Abstract
Using a large U.S. hospital database, we described 13,177 candidemia-associated hospitalizations during 2016–2024. In 2024, Candida glabrata surpassed C. albicans, and C. auris, previously rare, ranked fifth. These findings underscore the importance of ongoing surveillance and adherence to guidelines for candidemia treatment and testing.Keywords
This publication has 13 references indexed in Scilit:
- Molecular and Epidemiological Investigation of Fluconazole-resistant Candida parapsilosis—Georgia, United States, 2021Open Forum Infectious Diseases, 2024
- Worsening Spread of Candida auris in the United States, 2019 to 2021Annals of Internal Medicine, 2023
- COVID-19-associated candidiasis and the emerging concern of Candida auris infectionsJournal of Microbiology, Immunology and Infection, 2022
- COVID-19-associated fungal infectionsNature Microbiology, 2022
- The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) PandemicClinical Infectious Diseases, 2021
- Treatment Practices for Adults With Candidemia at 9 Active Surveillance Sites—United States, 2017–2018Clinical Infectious Diseases, 2021
- Changes in Prevalence of Health Care–Associated Infections in U.S. HospitalsNew England Journal of Medicine, 2018
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2015
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- Virulence in Candida speciesTrends in Microbiology, 2001